Won Jin Jeon

发表

Nivolumab plus ipilimumab induced endocrinopathy and acute interstitial nephritis in metastatic sarcomatoid renal-cell carcinoma: A case report and review of literature

Christopher Hino, H. Cao, Bryan Pham, 2022, Frontiers in Immunology.

Portal vein thrombosis as the presenting manifestation of JAK2 positive myeloproliferative neoplasm.

M. Akhtari, A. Nguyen, Won Jin Jeon, 2023, The American journal of the medical sciences.

Precision Medicine to Treat Urothelial Carcinoma—The Way Forward

G. Sonpavde, Ravand Samaeekia, Won Jin Jeon, 2023, Cancers.

Association of U.S. county social vulnerability with cancer mortality.

G. Nagaraj, H. Mirshahidi, Christopher Hino, 2022, Journal of Clinical Oncology.

Case Report: An exceptional response to neoadjuvant radiotherapy and chemotherapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use

L. Denham, Joel M. Brothers, Bryan Pham, 2023, Frontiers in Oncology.

Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management

P. Duerksen-Hughes, M. Reeves, D. Castillo, 2023, International journal of molecular sciences.

Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia.

D. Castillo, Y. Linhares, Joel M. Brothers, 2023, Hematology.

Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management.

P. Duerksen-Hughes, M. Reeves, D. Castillo, 2023, International journal of molecular sciences.

Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review

D. Castillo, Esther G. Chong, H. Cao, 2023, International journal of molecular sciences.

Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings

Won Jin Jeon, Daniel Park, Chieh Yang, 2024, Cancers.